WallStreetZenWallStreetZen

NASDAQ: CRGX
Cargo Therapeutics Inc Earnings & Revenue

CRGX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$98.1M
Current Profit Margin
0%

CRGX Return on Equity

Current Company
-53%
Current Industry
-63.5%
Current Market
188.7%
CRGX's Return on Equity (-53%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CRGX announces earnings.

CRGX Return on Assets

Current Company
-42.4%
Current Industry
2.9%
CRGX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CRGX Return on Capital Employed

Current Company
-22.35%
Current Industry
19.5%

CRGX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CRGX$0.00-$92.85M-$98.15MN/AN/A
ZNTL$0.00-$291.40M-$292.19M-100.00%N/A
SAGE$91.06M-$501.74M-$503.14M+0.07%N/A
ETNB$0.00-$133.26M-$142.19MN/AN/A
LBPH$0.00-$54.42M-$54.42MN/AN/A

Cargo Therapeutics Earnings & Revenue FAQ

What were CRGX's earnings last quarter?

On Invalid Date, Cargo Therapeutics (NASDAQ: CRGX) reported Q4 2023 earnings per share (EPS) of $81.62, up 423.38% year over year. Total Cargo Therapeutics earnings for the quarter were -$32.08 million. In the same quarter last year, Cargo Therapeutics's earnings per share (EPS) was -$25.24.

If you're new to stock investing, here's how to buy Cargo Therapeutics stock.

What was CRGX's earnings growth in the past year?

As of Q2 2024, Cargo Therapeutics's earnings has grown year over year. Cargo Therapeutics's earnings in the past year totalled -$98.15 million.

What was CRGX's revenue last quarter?

On Invalid Date, Cargo Therapeutics (NASDAQ: CRGX) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Cargo Therapeutics's revenue was $0.00.

What was CRGX's revenue growth in the past year?

As of Q2 2024, Cargo Therapeutics's revenue has grown null year over year. Cargo Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.